These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11878111)

  • 21. [Pharmacovigilance of self-medication].
    Montastruc JL; Bagheri H; Geraud T; Lapeyre-Mestre M
    Therapie; 1997; 52(2):105-10. PubMed ID: 9231503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of drug side effects over a year in a cardiology service].
    Jamaa M; Laine-Cessac P; Victor J; Tadei A; Allain P
    Therapie; 1993; 48(3):259-62. PubMed ID: 8140567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Iatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers of Pharmacovigilance].
    Imbs JL; Pouyanne P; Haramburu F; Welsch M; Decker N; Blayac JP; Bégaud B
    Therapie; 1999; 54(1):21-7. PubMed ID: 10216418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inappropriate drug use in the elderly: a nationwide register-based study.
    Johnell K; Fastbom J; Rosén M; Leimanis A
    Ann Pharmacother; 2007 Jul; 41(7):1243-8. PubMed ID: 17595305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy in elderly.
    Sandhiya S; Adithan C
    J Assoc Physicians India; 2008 Jul; 56():525-31. PubMed ID: 18846905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
    Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
    Bondon-Guitton E; Sommet A; Montastruc JL;
    Pharmacopsychiatry; 2009 Mar; 42(2):61-5. PubMed ID: 19308880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse drug effects observed at French admissions departments and emergency services (Prospective study of the National Educational Association for Teaching Therapeutics and proposals for preventive measures].
    Queneau P; Bannwarth B; Carpentier F; Guliana JM; Bouget J; Trombert B; Leverve X;
    Bull Acad Natl Med; 2003; 187(4):647-66; discussion 666-70. PubMed ID: 14556474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-related deaths in a university central hospital.
    Juntti-Patinen L; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 Oct; 58(7):479-82. PubMed ID: 12389071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highlights of the 22nd French pharmacovigilance meeting.
    Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adverse drug events in out-patients as the cause of an initial consultation to neurology].
    Ortin Castaño A; Otero MJ
    Neurologia; 2006 Jun; 21(5):232-8. PubMed ID: 16788865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse effects of oxybutynin chloride (Ditropan). Evaluation of the official survey of Regional Pharmacovigilance Centers].
    Jonville AP; Dutertre JP; Autret E; Barbellion M
    Therapie; 1992; 47(5):389-92. PubMed ID: 1299977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poisoning in older adults: a 5-year experience of US poison control centers.
    Crouch BI; Caravati EM; Mitchell A; Martin AC
    Ann Pharmacother; 2004 Dec; 38(12):2005-11. PubMed ID: 15522976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.